| (1S,2R,3R)-Aprepitant |
(1S,2R,3R)-阿瑞吡坦 |
1242175-34-3 |
| Benzoic acid, 2,4-dimethyl-, [4-[(1R)-1-(aminomethyl)-2-(6-isoquinolinylamino)-2-oxoethyl]phenyl]methyl ester |
Benzoic acid, 2,4-dimethyl-, [4-[(1R)-1-(aminomethyl)-2-(6-isoquinolinylamino)-2-oxoethyl]phenyl]methyl ester |
1254032-67-1 |
| Irinotecan Impurity 18 |
伊立替康杂质18 |
1255644-71-3 |
| Landiolol Hydrochloride EnantiomerⅢ（Benzenepropanoic acid, |
盐酸兰地洛尔异构体Ⅲ |
1253907-81-1 |
| R-7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-Methyl-10-(4-Methyl-1-piperazinyl)-7-oxo- Methyl ester |
R-9-氟-2,3-二氢-3-甲基-10-(4-甲基-1-哌嗪基)-7-氧代-7H-吡啶并[1,2,3-DE]-[1,4]苯并噁嗪-6-羧酸甲酯 |
1268719-66-9 |
| Moxifloxacin Impurity 38 |
莫西沙星杂质38 |
1262758-66-6 |
| AQMUMBCTNJGBGC-FGPIKTEISA-N |
甲地孕酮醋酸酯杂质G |
1259198-59-8 |
| Minodronic Acid Impurity 2 |
米诺磷酸杂质2 |
127657-45-8 |
| Melphalan Impurity B |
4-（4-吗啉基）-L-苯丙氨酸 |
1270153-04-2 |
| Vortioxetine Impurity 1 |
沃替西汀杂质A |
1293489-71-0 |
| Fusidic Acid Impurity J(EP) |
夫西地酸(褐霉酸)杂质J(EP) |
13011-12-6 |
| Epalrestat Impurity 4 |
Epalrestat Impurity 4 |
130786-32-2 |
| (R)-1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]ethanone |
依鲁替尼杂质31 |
1288338-95-3 |
| Vortioxetine Impurity 4 |
沃替西汀杂质4 |
1293489-77-6 |
| Vortioxetine Impurity 2 |
沃替西汀杂质2 |
1293489-69-6 |
| 4-[1-(4-cyano-3-trifluoromethyl-phenylcarbamoyl)-1-methyl-ethylamino]-2-fluoro-N- |
1289942-55-7 |
1289942-55-7 |
| (3aR,4S,7R,7aS)-2-[[(1S,2R)-2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione |
(3AR,4S,7R,7AS)-2-[[(1S,2R)-2-[[4-(1,2-苯并异噻唑-3-基)-1-哌嗪基]甲基]环己基]甲基]六氢-4,7-甲桥-1H-异吲哚-1,3(2H)-二酮 |
1318074-19-9 |
| 9H-Carbazole-1-acetic acid, 8-chloro- |
9H-Carbazole-1-acetic acid, 8-chloro- |
131023-44-4 |
| 7-ACT |
7-氨基头孢三嗪 |
131257-07-3 |
| Chlorhexidine Impurity B |
氯己定杂质B |
1308292-89-8 |
